|drug348||Azithromycin 500Mg Oral Tablet Wiki||0.71|
|drug345||Azithromycin 250 MG Wiki||0.71|
|drug1382||Glucose tablets Wiki||0.71|
|D000257||Adenoviridae Infections NIH||0.32|
There are 2 clinical trials
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.
Description: National Early Warning Score equal to zero is when patients recovered clinically. Respiration 14-20breaths/minute, oxygen saturation percent greater than 96, (without breathing aid), systolic blood pressure 111-180 mmhg, pulse 60-90 beats.minute, alert consciousness and 35.1-38 degree Celsius body temperature.Measure: National Early Warning Score equal to zero Time: 3-5 Days
Description: below 3.0 miligram/Liter of blood sampleMeasure: C-reactive proteins Time: 3-5 Days
Description: 1000 -4800 lymphocytes in 1 microliter of bloodMeasure: Lymphocyte Count Time: 3-5days
Description: less than 250 ng/mL, or less than 0.4 mcg/mL of blood sampleMeasure: d-dimers Time: 3-5days
This study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia
Description: Clinical recovery is defined as a complete resolution clinical signs appeared during the medical history and related to COVID-19.Measure: Clinical recovery at day-14, from the start of treatment. Time: 14 days
Description: RT-PCR will be realized in same laboratoryMeasure: Viral Clearance via RT-PCR at day 5- 7-10 and day 14 Time: 5- 7-10 and day 14
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports